{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:59:15Z","timestamp":1788325155831,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T00:00:00Z","timestamp":1342742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1038\/pr.2012.91","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T15:55:17Z","timestamp":1342799717000},"page":"400-406","source":"Crossref","is-referenced-by-count":18,"title":["Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic\u2013ischemic brain injury in rats"],"prefix":"10.1038","volume":"72","author":[{"given":"Silvia","family":"Carloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Alonso-Alconada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Girelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Duranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tontini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Hilario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Balduini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,20]]},"reference":[{"key":"BFpr201291_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D . The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003;4:873\u201384.","journal-title":"Nat Rev Neurosci"},{"key":"BFpr201291_CR2","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2174\/138161208785740117","volume":"14","author":"I Galve-Roperh","year":"2008","unstructured":"Galve-Roperh I, Aguado T, Palazuelos J, Guzm\u00e1n M . Mechanisms of control of neuron survival by the endocannabinoid system. Curr Pharm Des 2008;14:2279\u201388.","journal-title":"Curr Pharm Des"},{"key":"BFpr201291_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1525-1373.2000.22501.x","volume":"225","author":"TW Klein","year":"2000","unstructured":"Klein TW, Lane B, Newton CA, Friedman H . The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 2000;225:1\u20138.","journal-title":"Proc Soc Exp Biol Med"},{"key":"BFpr201291_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S1471-4914(02)02276-1","volume":"8","author":"R Mechoulam","year":"2002","unstructured":"Mechoulam R, Panikashvili D, Shohami E . Cannabinoids and brain injury: therapeutic implications. Trends Mol Med 2002;8:58\u201361.","journal-title":"Trends Mol Med"},{"key":"BFpr201291_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.neuroscience.2004.08.044","volume":"129","author":"S Muthian","year":"2004","unstructured":"Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ . Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Neuroscience 2004;129:743\u201350.","journal-title":"Neuroscience"},{"key":"BFpr201291_CR6","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/j.1471-4159.2007.04892.x","volume":"103","author":"M Degn","year":"2007","unstructured":"Degn M, Lambertsen KL, Petersen G, et al. Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. J Neurochem 2007;103:1907\u201316.","journal-title":"J Neurochem"},{"key":"BFpr201291_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1203\/01.pdr.0000228839.00122.6c","volume":"60","author":"D Fern\u00e1ndez-L\u00f3pez","year":"2006","unstructured":"Fern\u00e1ndez-L\u00f3pez D, Mart\u00ednez-Orgado J, Nu\u00f1ez E, et al. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats. Pediatr Res 2006;60:169\u201373.","journal-title":"Pediatr Res"},{"key":"BFpr201291_CR8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.neuroscience.2008.01.022","volume":"152","author":"M Zhang","year":"2008","unstructured":"Zhang M, Martin BR, Adler MW, Razdan RK, Ganea D, Tuma RF . Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic\/reperfusion injury. Neuroscience 2008;152:753\u201360.","journal-title":"Neuroscience"},{"key":"BFpr201291_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1742-4658.2008.06765.x","volume":"276","author":"DE Pellegrini-Giampietro","year":"2009","unstructured":"Pellegrini-Giampietro DE, Mannaioni G, Bagetta G . Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death. FEBS J 2009;276:2\u201312.","journal-title":"FEBS J"},{"key":"BFpr201291_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11481-009-9148-4","volume":"4","author":"M Zhang","year":"2009","unstructured":"Zhang M, Martin BR, Adler MW, et al. Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke. J Neuroimmune Pharmacol 2009;4:249\u201359.","journal-title":"J Neuroimmune Pharmacol"},{"key":"BFpr201291_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/35097089","volume":"413","author":"D Panikashvili","year":"2001","unstructured":"Panikashvili D, Simeonidou C, Ben-Shabat S, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 2001;413:527\u201331.","journal-title":"Nature"},{"key":"BFpr201291_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/mol.54.3.459","volume":"54","author":"M Shen","year":"1998","unstructured":"Shen M, Thayer SA . Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol 1998;54:459\u201362.","journal-title":"Mol Pharmacol"},{"key":"BFpr201291_CR13","doi-asserted-by":"publisher","first-page":"6475","DOI":"10.1523\/JNEUROSCI.21-17-06475.2001","volume":"21","author":"M van der Stelt","year":"2001","unstructured":"van der Stelt M, Veldhuis WB, B\u00e4r PR, Veldink GA, Vliegenthart JF, Nicolay K . Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity. J Neurosci 2001;21:6475\u20139.","journal-title":"J Neurosci"},{"key":"BFpr201291_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1203\/PDR.0b013e318123fbb8","volume":"62","author":"D Fern\u00e1ndez-L\u00f3pez","year":"2007","unstructured":"Fern\u00e1ndez-L\u00f3pez D, Pazos MR, Tol\u00f3n RM, et al. The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats. Pediatr Res 2007;62:255\u201360.","journal-title":"Pediatr Res"},{"key":"BFpr201291_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.brainres.2010.09.050","volume":"1362","author":"D Alonso-Alconada","year":"2010","unstructured":"Alonso-Alconada D, Alvarez FJ, Alvarez A, et al. The cannabinoid receptor agonist WIN 55,212-2 reduces the initial cerebral damage after hypoxic-ischemic injury in fetal lambs. Brain Res 2010;1362:150\u20139.","journal-title":"Brain Res"},{"key":"BFpr201291_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0074-7742(09)85005-8","volume":"85","author":"S Gaetani","year":"2009","unstructured":"Gaetani S, Dipasquale P, Romano A, et al. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. Int Rev Neurobiol 2009;85:57\u201372.","journal-title":"Int Rev Neurobiol"},{"key":"BFpr201291_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.neuropharm.2010.11.021","volume":"60","author":"E Landucci","year":"2011","unstructured":"Landucci E, Scartabelli T, Gerace E, Moroni F, Pellegrini-Giampietro DE . CB1 receptors and post-ischemic brain damage: studies on the toxic and neuroprotective effects of cannabinoids in rat organotypic hippocampal slices. Neuropharmacology 2011;60:674\u201382.","journal-title":"Neuropharmacology"},{"key":"BFpr201291_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nbd.2007.06.009","volume":"27","author":"S Carloni","year":"2007","unstructured":"Carloni S, Carnevali A, Cimino M, Balduini W . Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal rat. Neurobiol Dis 2007;27:354\u201361.","journal-title":"Neurobiol Dis"},{"key":"BFpr201291_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0006-8993(00)01997-1","volume":"859","author":"W Balduini","year":"2000","unstructured":"Balduini W, De Angelis V, Mazzoni E, Cimino M . Long-lasting behavioral alterations following a hypoxic\/ischemic brain injury in neonatal rats. Brain Res 2000;859:318\u201325.","journal-title":"Brain Res"},{"key":"BFpr201291_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1600-079X.2007.00503.x","volume":"44","author":"S Carloni","year":"2008","unstructured":"Carloni S, Perrone S, Buonocore G, Longini M, Proietti F, Balduini W . Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 2008;44:157\u201364.","journal-title":"J Pineal Res"},{"key":"BFpr201291_CR21","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1161\/hs0901.094287","volume":"32","author":"W Balduini","year":"2001","unstructured":"Balduini W, De Angelis V, Mazzoni E, Cimino M . Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic\/ischemic brain injury. Stroke 2001;32:2185\u201391.","journal-title":"Stroke"},{"key":"BFpr201291_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.brainres.2008.09.019","volume":"1240","author":"M Schomacher","year":"2008","unstructured":"Schomacher M, M\u00fcller HD, Sommer C, Schwab S, Sch\u00e4bitz WR . Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Brain Res 2008;1240:213\u201320.","journal-title":"Brain Res"},{"key":"BFpr201291_CR23","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1124\/mol.104.002071","volume":"66","author":"TP Dinh","year":"2004","unstructured":"Dinh TP, Kathuria S, Piomelli D . RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol 2004;66:1260\u20134.","journal-title":"Mol Pharmacol"},{"key":"BFpr201291_CR24","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/nn1521","volume":"8","author":"JK Makara","year":"2005","unstructured":"Makara JK, Mor M, Fegley D, et al. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat Neurosci 2005;8:1139\u201341.","journal-title":"Nat Neurosci"},{"key":"BFpr201291_CR25","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nature03658","volume":"435","author":"AG Hohmann","year":"2005","unstructured":"Hohmann AG, Suplita RL, Bolton NM, et al. An endocannabinoid mechanism for stress-induced analgesia. Nature 2005;435:1108\u201312.","journal-title":"Nature"},{"key":"BFpr201291_CR26","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.chembiol.2007.10.017","volume":"14","author":"AR King","year":"2007","unstructured":"King AR, Duranti A, Tontini A, et al. URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. Chem Biol 2007;14:1357\u201365.","journal-title":"Chem Biol"},{"key":"BFpr201291_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/sj.bjp.0707425","volume":"152","author":"F Comelli","year":"2007","unstructured":"Comelli F, Giagnoni G, Bettoni I, Colleoni M, Costa B . The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation. Br J Pharmacol 2007;152:787\u201394.","journal-title":"Br J Pharmacol"},{"key":"BFpr201291_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.nbd.2005.11.004","volume":"22","author":"D Panikashvili","year":"2006","unstructured":"Panikashvili D, Shein NA, Mechoulam R, et al. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 2006;22:257\u201364.","journal-title":"Neurobiol Dis"},{"key":"BFpr201291_CR29","doi-asserted-by":"publisher","first-page":"22601","DOI":"10.1074\/jbc.M800524200","volume":"283","author":"J Zhang","year":"2008","unstructured":"Zhang J, Chen C . Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation. J Biol Chem 2008;283:22601\u201311.","journal-title":"J Biol Chem"},{"key":"BFpr201291_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ana.410090206","volume":"9","author":"JE Rice","year":"1981","unstructured":"Rice JE 3rd, Vannucci RC, Brierley JB . The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981;9:131\u201341.","journal-title":"Ann Neurol"},{"key":"BFpr201291_CR31","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1021\/jm021119g","volume":"46","author":"G Tarzia","year":"2003","unstructured":"Tarzia G, Duranti A, Tontini A, et al. Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors. J Med Chem 2003;46:2352\u201360.","journal-title":"J Med Chem"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr201291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201291","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:57:32Z","timestamp":1684472252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr201291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,20]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["BFpr201291"],"URL":"https:\/\/doi.org\/10.1038\/pr.2012.91","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,20]]}}}